Ophthalmology

49-51 of 51

• 

  RestartResume

  Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying

  RestartResume

  Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying

  CME/CE

  Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying

  Carl Regillo, MD; Jennifer I. Lim, MD, FARVO

  0.25 credits

  • 

    

    Carl Regillo, MD

  • 

    

    Jennifer I. Lim, MD, FARVO

  0.25 credits

• 

  RestartResume

  Mechanisms of Pressure Relief in Glaucoma: Pharmacologic & Surgical Advances for Refractory POAG or Non-Adherence

  RestartResume

  Mechanisms of Pressure Relief in Glaucoma: Pharmacologic & Surgical Advances for Refractory POAG or Non-Adherence

  CME/CE

  Mechanisms of Pressure Relief in Glaucoma: Pharmacologic & Surgical Advances for Refractory POAG or Non-Adherence

  David S. Friedman, MD, PhD, MPH; Steven J. Gedde, MD

  • 

    

    David S. Friedman, MD, PhD, MPH

  • 

    

    Steven J. Gedde, MD

  • 

    

    W. Daniel Stamer, PhD

• 

  RestartResume

  Curing Blindness: How Researchers are Utilizing Gene Therapy

  RestartResume

  Curing Blindness: How Researchers are Utilizing Gene Therapy

  Medical Breakthroughs from Penn Medicine

  Curing Blindness: How Researchers are Utilizing Gene Therapy

  Shira Johnson, MD; Jean Bennett, MD, PhD

  • 

    

    Shira Johnson, MD

  • 

    

    Jean Bennett, MD, PhD

• Previous
• 1
• 2
• 3
• 4
• Next